Monosodium glutamate neurotoxicity increases beta amyloid in the rat hippocampus: A potential role for cyclic AMP protein kinase

NeuroToxicology

Volumn 42, Issue , 2014, Pages 76-82

  Dief, Abeer E ^a   Kamha, Eman S ^a   Baraka, Azza M ^a   Elshorbagy, Amany K ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

AMPK; Apoptosis; Behavioral; Excitotoxicty; T maze

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; FAS LIGAND; GLUTAMATE SODIUM; PIOGLITAZONE; PLACEBO; 2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUTAMIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ABNORMAL BEHAVIOR; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; APOPTOSIS; ARTICLE; BLACK WHITE ALLEY TEST; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; HIPPOCAMPUS; HOLE BOARD TEST; MALE; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RAT MODEL; TOXICOKINETICS; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; NERVE DEGENERATION;

AMP-ACTIVATED PROTEIN KINASES; AMYLOID BETA-PEPTIDES; ANIMALS; BEHAVIOR, ANIMAL; FAS LIGAND PROTEIN; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NERVE DEGENERATION; RATS; SODIUM GLUTAMATE; THIAZOLIDINEDIONES;

EID: 84899874544     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.04.003     Document Type: Article

References (50)

1. Ali M.M., Bawari M., Misra U.K., Babu G.N. Locomotor and learning deficits in adult rats exposed to monosodium-l-glutamate during early life. Neurosci Lett 2000, 284(1-2):57-60.
2. Beas-Zarate C., Perez-Vega M., Gonzalez-Burgos I. Neonatal exposure to monosodium l-glutamate induces loss of neurons and cytoarchitectural alterations in hippocampal CA1 pyramidal neurons of adult rats. Brain Res 2002, 952(2):275-281.
3. Becker E.B., Oliver P.L., Glitsch M.D., Banks G.T., Achilli F., Hardy A., et al. A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. Proc Natl Acad Sci U S A 2009, 106(16):6706-6711.
4. Beyreuther K., Biesalski H.K., Fernstrom J.D., Grimm P., Hammes W.P., Heinemann U., et al. Consensus meeting: monosodium glutamate - an update. Eur J Clin Nutr 2007, 61(3):304-313.
5. Bordji K., Becerril-Ortega J., Nicole O., Buisson A. Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ss production. J Neurosci 2010, 30(47):15927-15942.
6. Braak H., Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl 1998, 53:127-140.
7. Burde R.M., Schainker B., Kayes J. Acute effect of oral and subcutaneous administration of monosodium glutamate on the arcuate nucleus of the hypothalamus in mice and rats. Nature 1971, 233(5314):58-60.
8. Cai Z., Li B., Li K., Zhao B. Down-regulation of amyloid-beta through AMPK activation by inhibitors of GSK-3beta in SH-SY5Y and SH-SY5Y-AbetaPP695 cells. J Alzheimers Dis 2012, 29(1):89-98.
9. Clarke G., O'Mahony S., Malone G., Dinan T.G. An isocratic high performance liquid chromatography method for the determination of GABA and glutamate in discrete regions of the rodent brain. J Neurosci Methods 2007, 160(2):223-230.
10. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 2005, 8(1):79-84.
11. Contet C., Rawlins J.N., Deacon R.M. A comparison of 129S2/SvHsd and C57BL/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice. Behav Brain Res 2001, 124(1):33-46.
12. Crawley J., Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 1980, 13(2):167-170.
13. Culmsee C., Monnig J., Kemp B.E., Mattson M.P. AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 2001, 17(1):45-58.
14. Deacon R.M.J. APP-based transgenic models: the Tg2576 model. Animal models of dementia 2011, Humana Press, New York. P.P. De Deyn, D. Van Dam (Eds.).
15. Deacon R.M., Croucher A., Rawlins J.N. Hippocampal cytotoxic lesion effects on species-typical behaviours in mice. Behav Brain Res 2002, 132(2):203-213.
16. Greco S.J., Hamzelou A., Johnston J.M., Smith M.A., Ashford J.W., Tezapsidis N. Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and beta-amyloid in neurons. Biochem Biophys Res Commun 2011, 414(1):170-174.
17. Grewer C., Gameiro A., Zhang Z., Tao Z., Braams S., Rauen T. Glutamate forward and reverse transport: from molecular mechanism to transporter-mediated release after ischemia. IUBMB Life 2008, 60(9):609-619.
18. Harkany T., Dijkstra I.M., Oosterink B.J., Horvath K.M., Abraham I., Keijser J., et al. Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine. Neuroscience 2000, 101(1):101-114.
19. Hlinak Z., Gandalovicova D., Krejci I. Behavioral deficits in adult rats treated neonatally with glutamate. Neurotoxicol Teratol 2005, 27(3):465-473.
20. Hynd M.R., Scott H.L., Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 2004, 45(5):583-595.
21. Ikeda H., Taketomi S., Sugiyama Y., Shimura Y., Sohda T., Meguro K., et al. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneimittelforschung 1990, 40(2 Pt 1):156-162.
22. Inestrosa N.C., Godoy J.A., Quintanilla R.A., Koenig C.S., Bronfman M. Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling. Exp Cell Res 2005, 304(1):91-104.
23. Jack C.R., Lowe V.J., Weigand S.D., Wiste H.J., Senjem M.L., Knopman D.S., et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009, 132(Pt 5):1355-1365.
24. Kiss P., Tamas A., Lubics A., Szalai M., Szalontay L., Lengvari I., et al. Development of neurological reflexes and motor coordination in rats neonatally treated with monosodium glutamate. Neurotox Res 2005, 8(3-4):235-244.
25. Lesne S., Ali C., Gabriel C., Croci N., MacKenzie E.T., Glabe C.G., et al. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci 2005, 25(41):9367-9377.
26. Lopez-Perez S.J., Urena-Guerrero M.E., Morales-Villagran A. Monosodium glutamate neonatal treatment as a seizure and excitotoxic model. Brain Res 2010, 1317:246-256.
27. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193(1):265-275.
28. Mehta A., Prabhakar M., Kumar P., Deshmukh R., Sharma P.L. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol 2013, 698(1-3):6-18.
29. Meldrum B.S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000, 130(4S Suppl.):1007S-1015S.
30. Moon H.S., Dincer F., Mantzoros C.S. Amylin-induced downregulation of hippocampal neurogenesis is attenuated by leptin in a STAT3/AMPK/ERK-dependent manner in mice. Diabetologia 2013, 56(3):627-634.
31. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 2001, 21(19):7551-7560.
32. Mormino E.C., Kluth J.T., Madison C.M., Rabinovici G.D., Baker S.L., Miller B.L., et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 2009, 132(Pt 5):1310-1323.
33. Ndountse L.T., Chan H.M. Role of N-methyl-d-aspartate receptors in polychlorinated biphenyl mediated neurotoxicity. Toxicol Lett 2009, 184(1):50-55.
34. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969, 164(3880):719-721.
35. Olvera-Cortes E., Lopez-Vazquez M.A., Beas-Zarate C., Gonzalez-Burgos I. Neonatal exposure to monosodium glutamate disrupts place learning ability in adult rats. Pharmacol Biochem Behav 2005, 82(2):247-251.
36. Perez V.J., Olney J.W., Martin J.F., Cannon W.O. Minimal tissue concentrations of glutamate required to produce necrosis of hypothalamic neurons in newborn mice. Biol Neonate 1979, 35(1-2):17-22.
37. Rivera-Cervantes M.C., Torres J.S., Feria-Velasco A., Armendariz-Borunda J., Beas-Zarate C. NMDA and AMPA receptor expression and cortical neuronal death are associated with p38 in glutamate-induced excitotoxicity in vivo. J Neurosci Res 2004, 76(5):678-687.
38. Robinson S.R., Bishop G.M. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol Aging 2002, 23(6):1051-1072.
39. Salminen A., Kaarniranta K., Haapasalo A., Soininen H., Hiltunen M. AMP-activated protein kinase: a potential player in Alzheimer's disease. J Neurochem 2011, 118(4):460-474.
40. Segura Torres J.E., Chaparro-Huerta V., Rivera Cervantres M.C., Montes-Gonzalez R., Flores Soto M.E., Beas-Zarate C. Neuronal cell death due to glutamate excitotocity is mediated by p38 activation in the rat cerebral cortex. Neurosci Lett 2006, 403(3):233-238.
41. Shen J.Z., Ma L.N., Han Y., Liu J.X., Yang W.Q., Chen L., et al. Pentamethylquercetin generates beneficial effects in monosodium glutamate-induced obese mice and C2C12 myotubes by activating AMP-activated protein kinase. Diabetologia 2012, 55(6):1836-1846.
42. Tanzi R.E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005, 120(4):545-555.
43. Tehranian R., Rose M.E., Vagni V., Pickrell A.M., Griffith R.P., Liu H., et al. Disruption of Bax protein prevents neuronal cell death but produces cognitive impairment in mice following traumatic brain injury. J Neurotrauma 2008, 25(7):755-767.
44. Vingtdeux V., Giliberto L., Zhao H., Chandakkar P., Wu Q., Simon J.E., et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem 2010, 285(12):9100-9113.
45. Vingtdeux V., Chandakkar P., Zhao H., d'Abramo C., Davies P., Marambaud P. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation. FASEB J 2011, 25(1):219-231.
46. Wei W., Nguyen L.N., Kessels H.W., Hagiwara H., Sisodia S., Malinow R. Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci 2010, 13(2):190-196.
47. Wilkinson D., Wirth Y., Goebel C. Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response. Dement Geriatr Cogn Disord 2014, 37(1-2):71-85.
48. Won J.S., Im Y.B., Kim J., Singh A.K., Singh I. Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis. Biochem Biophys Res Commun 2010, 399(4):487-491.
49. Yao M., Nguyen T.V., Pike C.J. Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci 2005, 25(5):1149-1158.
50. Zhang W., Wu R., Zhang F., Xu Y., Liu B., Yang Y., et al. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway. Clin Exp Pharmacol Physiol 2012, 39(12):1026-1033.